Screener
Insight Molecular Diagnostics Inc. IMDX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Insight Molecular Diagnostics Inc.’s reported figures.
The source filing: Insight Molecular Diagnostics Inc.’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001642380-26-000008
FAQ
- What is Insight Molecular Diagnostics Inc.'s invested capital?
- Insight Molecular Diagnostics Inc. (IMDX) reported invested capital of -$36M in Q1 2026.
- How has Insight Molecular Diagnostics Inc.'s invested capital changed year-over-year?
- Insight Molecular Diagnostics Inc.'s invested capital decreased by 106.0% year-over-year, from -$17.47M to -$36M.
- What is the long-term trend for Insight Molecular Diagnostics Inc.'s invested capital?
- Over 3 years (2020 to 2025), Insight Molecular Diagnostics Inc.'s invested capital has grown at a 13.9% compound annual growth rate (CAGR), from $26.86M to -$39.73M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Insight Molecular Diagnostics Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude